← Back to Search

Acceptance Commitment Therapy for Methamphetamine Addiction

N/A
Waitlist Available
Led By Bernard Le Foll, MD
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month follow up
Awards & highlights

Study Summary

This trial is testing a new way to help women with methamphetamine addiction, using a combination of therapy and a phone app. The hope is that this will be more effective than traditional methods, and that it can be done from home.

Who is the study for?
This trial is for women and gender non-conforming individuals with methamphetamine use disorder (MUD), who can consent, communicate in English, and have a clinician. It's not for those with severe cognitive issues, untreated psychosis, or intense suicidal thoughts needing hospitalization.Check my eligibility
What is being tested?
The study tests Acceptance Commitment Therapy combined with motivation enhancement and the ChillTime App to reduce methamphetamine use remotely. Participants can join from home unless it's unsafe or unfeasible.See study design
What are the potential side effects?
Since this trial involves therapy and app usage rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort while discussing personal issues during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month follow up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of intervention
Feasibility of intervention
Secondary outcome measures
Barriers to engaging in the intervention using qualitative assessments at the end of study
Changes in acceptance commitment skills via the Acceptance and Action Questionnaire [AAQ-2
Changes in anxiety via the Generalized Anxiety Disorder-7 (GAD-7)
+9 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants will complete the baseline session, a 1:1 motivation building session, and 8 weeks of ACT group therapy. They will then complete a final study visit and a follow-up study visit to occur 6 month after the end of therapy.

Find a Location

Who is running the clinical trial?

Centre for Addiction and Mental HealthLead Sponsor
354 Previous Clinical Trials
81,060 Total Patients Enrolled
Bernard Le Foll, MDPrincipal InvestigatorCentre for Addiction and Mental Health
1 Previous Clinical Trials
10 Total Patients Enrolled
David Castle, MDPrincipal InvestigatorCentre for Addiction and Mental Health

Media Library

Acceptance Commitment Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05334914 — N/A
Methamphetamine Abuse Research Study Groups: Intervention Arm
Methamphetamine Abuse Clinical Trial 2023: Acceptance Commitment Therapy Highlights & Side Effects. Trial Name: NCT05334914 — N/A
Acceptance Commitment Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05334914 — N/A
Methamphetamine Abuse Patient Testimony for trial: Trial Name: NCT05334914 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the fundamental aims of this trial?

"This trial, which will be closely monitored for a short duration post-intervention, aims to measure the efficacy of this intervention. Secondary outcomes include changes in other substance use and methamphetamine use as measured by Timeline Followback (TLFB) over the last 7 days, as well as shifts in anxiety levels assessed via Generalized Anxiety Disorder-7 (GAD-7)."

Answered by AI

Is this experiment recruiting participants at present?

"It appears that this clinical trial is no longer accepting patients, as indicated by the data hosted on clinicialtrials.gov. This study was initially posted at the start of 2023 and its last edit was made in July 2022. Fortunately, 24 other studies are currently seeking participants to join them."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
Centre for Addiction and Mental Health
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
3+

Why did patients apply to this trial?

I have tried many other treatments center grups counseling meds and even jail.
PatientReceived 1 prior treatment
Well, I live in New York if it’s only one or two visits, then it would be a possibility to do it depending on if the gas is Cover.
PatientReceived 2+ prior treatments

How responsive is this trial?

Average response time
  • < 1 Day
Typically responds via
Email
Most responsive sites:
  1. Centre for Addiction and Mental Health: < 24 hours
Recent research and studies
clinicaltrials.govStudy
ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals
Bernard Le Foll 2024. "ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05334914.
~40 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top